Alcohol Research Programs

Active

Assistance listing
93.273
Agency
Grant awards
10,529 $10,797,874,608 in federal obligations

Program facts

Assistance types
  • Project Grant
  • Cooperative Agreement
  • Block Grant
Treasury account
  • 75-0894-0-1-552
More information

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the Department of Health and Human Services National Institutes of Health administers the Alcohol Research Programs (CFDA 93.273), which funds biomedical, genetic, psychological, environmental, and health services research on alcohol-related problems, treatment methods, and prevention strategies, with the most recent grant award dated February 25, 2027.

The program funds research spanning molecular and cellular mechanisms of alcohol-related disease, behavioral and clinical outcomes, and intervention development. Recent awards illustrate the scope: investigations into how PFAS and alcohol co-exposure worsen liver disease; music training's effects on brain connectivity in children with fetal alcohol spectrum disorder; psychedelic compounds' mechanisms for reducing alcohol consumption; and pain processing changes after adolescent alcohol exposure. The portfolio also encompasses epidemiological studies, implementation science projects evaluating treatment access barriers, and digital health interventions for alcohol use disorder prevention and recovery.

Project Grants constitute 93 percent of the award portfolio, with Block Grants at 4 percent and Cooperative Agreements at 3 percent. The National Institute on Alcohol Abuse and Alcoholism dominates funding, accounting for 3,474 awards worth $7.58 billion in federal dollars obligated—representing 72 percent of combined federal dollars across the program. The broader NIAAA operates within NIH, which issued the remaining awards through subordinate programs. Combined federal dollars obligated total $10.8 billion across 10,529 awards spanning from 1977 to February 2027. Recent activity shows a declining trend: 304 awards in 2023, declining to 179 in 2026 and 13 awards through early 2027.

Award magnitudes range widely, from under $100 thousand for postdoctoral fellowships to multi-million-dollar research and center grants. Representative recent awards include investigations of skeletal muscle loss in alcohol-associated liver disease ($353 thousand), text-message interventions for young adult drinkers ($670 thousand), and employer strategies to expand alcohol use disorder treatment access ($2.73 million).

Recent grant opportunities posted include the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) U19 program (forecast posted October 6, 2026), supporting coordinated multidisciplinary research on fetal alcohol spectrum disorders; and the HIV Prevention and Alcohol R61/R33 opportunity (posted October 1, 2026), supporting phased innovation in alcohol-integrated HIV prevention interventions. The CIFASD opportunity targets improved early identification, intervention development, and prevention research. The HIV Prevention and Alcohol opportunity emphasizes development and pilot testing in the R61 phase, with expanded testing in the R33 phase for effectiveness and implementation studies addressing alcohol use and comorbidities. Both opportunities welcome applications from higher education institutions, nonprofits, state and tribal entities, and small businesses.

Objective and description

Objective

To develop a sound fundamental knowledge base which can be applied to the development of improved methods of treatment and more effective strategies for preventing alcoholism and alcohol-related problems. The National Institute on Alcohol Abuse and A

Description

To develop a sound fundamental knowledge base which can be applied to the development of improved methods of treatment and more effective strategies for preventing alcoholism and alcohol-related problems. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) supports research in a broad range of disciplines and subject areas related to biomedical and genetic factors, psychological and environmental factors, alcohol-related problems and medical disorders, health services research, and prevention and treatment research.

Eligibility

Applicant eligibility

Public or private profit and nonprofit agencies, including State, local, or regional government agencies, universities, colleges, hospitals, academic or research institutions may apply for research grants. SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed, and have no more than 500 employees). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council. STTR grants can be awarded only to domestic small business concerns (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed and have no more than 500 employees) which "partner" with a research institution in cooperative research and development. At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.

Beneficiary eligibility

Public, profit and nonprofit private organizations.

Uses of assistance

(1) Research Project Grants provide support for clearly defined projects or a small group of related activities, and when appropriate, support of conferences; (2) Program Project Grants are for large-scale, broad-based programs of research, usually interdisciplinary, consisting of several projects with a common focus; (3) Small Grants are for small-scale exploratory and pilot studies or exploration of an unusual research opportunity; Small Grants are limited to $50,000 for direct costs for a period of up to 2 years; (4) Exploratory/Developmental Grants are limited for a period of up to 2 years, and a maximum of $275,000 for direct costs for the entire 2- year period. Funds may be used only for expenses directly related to the approved research project. SBIR Phase I grants (of approximately 6- months' duration) are to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or processes. Phase II grants are for the continuation of the research initiated in Phase I, and that are likely to result in commercial products or processes. STTR Phase I grants (normally of 1-year duration) are to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort that has potential for commercial application. Phase II funding is based on results of research initiated in Phase I and scientific and technical merit and commercial potential of Phase II application; (5). Alcohol Research Center Grants, and Alcohol Research Resource Centers provide long-term support for a concerted and multi-disciplinary research effort into the problems of alcohol use and alcoholism by coordinating the activities of investigators from biomedical, behavioral, and social science disciplines around a basic research theme. An alcohol research center is expected to realize its greater potential for contributing to the basic store of knowledge about alcohol and alcoholism and to become a significant regional and national resource; (6) Training and Research Career Development awards - Mentored Research Scientist Development Awards (K01), Mentored Clinical Scientist Development Awards (K08), and Independent Scientist Awards (K02) provide support for individuals with research potential who need additional development and/or experience in a productive research environment. Mentored Patient-Oriented Research Career Development Award (K23) and Mid-career Investigator Award in Patient Oriented Research (K24) and Mentored Quantitative Research Career Development Award (K25) are also available. Senior Scientist Awards (K05) are also available to enable senior investigators to devote full-time to research. Academic Career Awards (K07) are also available for clinical faculty development; and (7)Alcohol National Research Service Awards for Research Training awards to assure the maintenance of an adequate supply of well-trained alcohol researchers through the award of both individual fellowships and grants to training institutions for support of training at both the pre-doctoral and postdoctoral levels and for Senior Fellowships and M.D./Ph.D. Fellowships. Special pre-doctoral fellowships are also available for students with disabilities and for minority students.

Length and time phasing of assistance

Varies, but a project period is generally limited to 5 years or less. Grantee may apply for renewal of support on a competing basis. Within the project period, continuation applications must be submitted on a non-competing basis for each year of approved support. Small Grants are limited to 2 years or less and are not renewable. Exploratory/Developmental Grants are limited to 3 years or less and are not renewable. Payments will be made either on a Monthly Cash Request System or under an Electronic Transfer System. Necessary instructions for the appropriate type of payment will be issued shortly after an award is made. SBIR: Normally, Phase I awards are for 6 months; normally, Phase II awards are for 2 years. STTR: Normally, Phase I awards are for 1 year; normally, Phase II awards are for 2 years.

How to apply

Criteria for selecting proposals

The following considerations will be used in determining projects to be funded: (1) Scientific and technical merit of the proposal; (2) program balance; and (3) relevance to NIAAA priorities and public health issues. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human of animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which Phase I objectives were met and feasibility demonstrated; (2) the scientific and technical merit of the proposed approach for achieving the Phase II objectives; (3) the qualifications of the proposed principal investigator, supporting staff, and consultants; (4) the technological innovation, originality, or societal importance of the proposed research; (5) the potential of the proposed research for commercial application; (6) the reasonableness of the budget requested for the work proposed; (7) the adequacy and suitability of the facilities and research environment; and (8) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment.

Award procedure

Research Grants in support of projects recommended for approval by the National Advisory Council on Alcohol Abuse and Alcoholism and approved for payment are awarded directly by the NIAAA to the applicant institution. All accepted SBIR/STTR applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by a national advisory council or board. All applications receiving a priority score compete for available SBIR/STTR set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, program relevance, and program balance among the areas of research.

Time to approval or disapproval

From 240 to 270 days from submission of application for grant support. SBIR/STTR applications about 7-1/2 months. AIDS related research applications about 6 months.

Renewals

Support is recommended for a specified project period, usually not in excess of 5 years. Prior to termination of a project period, the grantee may apply for renewal of support for a new project period. An application for renewal is processed as a competing request. Small Grants and Exploratory/Developmental Grants are not renewable, but grantees may apply for research project grants on the same topics.

Appeals

A principal investigator may appeal the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeals procedures is available on the NIH home page http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html

Grant opportunities

Opportunity Status Posted Applications due
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional) RFA-AA-28-002 Forecasted —
HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional) PAS-28-073 Forecasted —
HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) RFA-DA-27-016 Open
Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) PAR-27-040 Forecasted —
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) PAR-27-039 Forecasted —
NIH Specialized Center Grant (Parent P50) PA-28-011 Forecasted —
Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional) PAR-27-003 Open
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) PAR-27-045 Open
NIH Research Program Projects (Parent P01 Clinical Trial Optional) PA-27-061 Open
Specialized Alcohol Research Centers (P50 Clinical trial Optional) RFA-AA-28-001 Open
Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) PAR-27-076 Open
NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) PA-26-002 Open
NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed) PA-27-036 Open
NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed) PA-27-035 Open
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) RFA-AI-27-018 Open
NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed) PAR-27-051 Open
BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed) RFA-NS-27-002 Open
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) RFA-NS-28-010 Open
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 Open
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) RFA-DA-28-012 Open
HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) RFA-DA-28-011 Open
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) PA-27-100 Open
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) PA-27-102 Open
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) PA-27-101 Open
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR-27-078 Open
NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed) PA-27-034 Open
Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed) PA-27-037 Open
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) PAR-27-098 Open
BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) RFA-DC-27-004 Open
Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Study Renewal - Data Analysis, Informatics and Resource Center, and Coordinating Center (U24 Clinical Trial Not Allowed) RFA-DA-27-003 Closed
Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Study-Research Project Sites (U01 Clinical Trial Not Allowed) RFA-DA-27-002 Closed
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) RFA-NS-27-007 Open
Small Business Translator: MedTech and Digital Health Technologies FOR-NS-25-017 Past —
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) RFA-DA-27-004 Open
Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (Collaborative U24 - Clinical Trials not allowed) NOT-AA-25-006 Past —
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional) NOT-AA-25-014 Past —
Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (Collaborative U24 - Clinical Trials not allowed) NOT-AA-25-007 Past —
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional) NOT-AA-25-013 Past —
HEAL INITIATIVE: INTERACT Data Coordination and Integration Center (U24 Clinical Trial Not Allowed) RFA-AR-27-002 Closed
Forecast to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01 Clinical Trials Optional) NOT-AA-25-012 Past —
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) PAR-25-415 Open
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) PAR-25-322 Open
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required) PAR-25-323 Closed
HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development (HBCD) Study - Consortium Administrative Core and Data Coordinating Center (U24 Clinical Trial Not Allowed) RFA-DA-27-014 Closed
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) PAR-25-414 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) PA-25-425 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) PA-25-422 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) PA-25-423 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) PA-25-426 Open
Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional) NOT-AA-25-009 Past —
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Grant awards

Award Recipient Federal obligations Awarded
The impact and mechanisms of PFAS on alcohol-associated liver disease F32AA032967 Yale Univ $80,320
Early life stress effects on insula function and alcohol use disorder vulnerability F31AA033558 Wake Forest University Health Sciences $50,114
Determining mechanisms of psychedelic action on reducing alcohol consumption F31AA033513 Virginia Commonwealth University $45,102
Investigating the roles, properties, and signaling dynamics of central amygdala neurotensin neurons in alcohol use… F31AA032988 University Of North Carolina At Chapel Hill $41,658
Determining the role of anterior insular cortex parvalbumin-positive interneuron function in aversion-resistant alcohol… F31AA032987 University Of North Carolina At Chapel Hill $41,658
Changes in pain processing after adolescent alcohol exposure F31AA032982 The Research Foundation For The State University Of New York $35,432
Music training's effect on brain functional connectivity in children with fetal alcohol spectrum disorder F30AA033608 University Of New Mexico $45,354
Investigating the impact of adolescent intermittent ethanol on GLP-1R function in central amygdala - fproject… F32AA032740 The Research Foundation For The State University Of New York $79,348
Investigating cortico-limbic ensemble dynamics during alcohol consumption F31AA033517 The Medical University Of South Carolina $50,114
The impact of high-intensity drinking on molecular and electrophysiological plasticity in the nucleus accumbens F31AA033550 University Of New Mexico $40,193

Latest 10 of 10,529 listed here. See the rest on GovTribe.

Top recipients by federal obligations

10 of 649 recipients listed here. See the rest on GovTribe.

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2026 $417,555,096
FY2025 $665,538,530
FY2024 $765,096,541
FY2023 $993,135,914
FY2022 $992,708,542
FY2021 $832,062,682
FY2020 $409,740,727
FY2019 $389,104,601
FY2018 $380,398,795
FY2017 $352,407,748
FY2016 $343,191,171
FY2015 $328,570,493
FY2014 $335,003,987
FY2013 $322,707,447
FY2012 $342,567,231
FY2011 $338,572,038
FY2010 $327,063,438
FY2009 $313,946,526
FY2008 $152,406,442
FY2007 $207,527,709
FY2006 $279,124,566
FY2005 $283,776,991
FY2004 $283,001,410
FY2003 $266,708,036
FY2002 $250,739,160
FY2001 $131,376,034
Show all 26

Quick answers

What is Assistance Listing 93.273?

Assistance Listing 93.273 is Alcohol Research Programs, a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for Alcohol Research Programs?

Its CFDA number is 93.273: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.273 awarded?

10,529 grant awards under 93.273 have obligated $10,797,874,608 in federal funds to 649 recipients.

Who receives the most funding from 93.273?

The recipients obligated the most under Alcohol Research Programs are Yale Univ ($358,567,827), University Of North Carolina At Chapel Hill ($280,080,760) and Trustees Of Indiana University ($251,895,536).

How much did 93.273 obligate in fiscal year 2025?

Grants under 93.273 obligated $665,538,530 in federal funds in fiscal year 2025.

Are there open grant opportunities under 93.273?

38 of the latest 50 opportunities under 93.273 are open or forecasted. The latest, Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional), was posted on October 6, 2026.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program